81 related articles for article (PubMed ID: 9279070)
1. [Tumor angiogenesis and Flt tyrosine kinase].
Shibuya M
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1470-6. PubMed ID: 9279070
[No Abstract] [Full Text] [Related]
2. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
3. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
4. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
5. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
7. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
DeFouw LM; DeFouw DO
Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
[TBL] [Abstract][Full Text] [Related]
9. ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.
Whittles CE; Pocock TM; Wedge SR; Kendrew J; Hennequin LF; Harper SJ; Bates DO
Microcirculation; 2002 Dec; 9(6):513-22. PubMed ID: 12483548
[TBL] [Abstract][Full Text] [Related]
10. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
11. From angiogenesis to lymphangiogenesis.
Plate K
Nat Med; 2001 Feb; 7(2):151-2. PubMed ID: 11175837
[No Abstract] [Full Text] [Related]
12. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
Karkkainen MJ; Petrova TV
Oncogene; 2000 Nov; 19(49):5598-605. PubMed ID: 11114740
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.
Igarashi K; Isohara T; Kato T; Shigeta K; Yamano T; Uno I
Biochem Biophys Res Commun; 1998 May; 246(1):95-9. PubMed ID: 9600074
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
Kuo CJ; Farnebo F; Yu EY; Christofferson R; Swearingen RA; Carter R; von Recum HA; Yuan J; Kamihara J; Flynn E; D'Amato R; Folkman J; Mulligan RC
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4605-10. PubMed ID: 11274374
[TBL] [Abstract][Full Text] [Related]
16. The Id proteins and angiogenesis.
Benezra R; Rafii S; Lyden D
Oncogene; 2001 Dec; 20(58):8334-41. PubMed ID: 11840326
[TBL] [Abstract][Full Text] [Related]
17. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
18. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
Plouet J
Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
[No Abstract] [Full Text] [Related]
19. Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials.
Maru Y; Yamaguchi S; Shibuya M
Oncogene; 1998 May; 16(20):2585-95. PubMed ID: 9632135
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia--a key regulatory factor in tumour growth.
Harris AL
Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
